C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note
Section:
 

Relative Value

The Relative Value of one CARA stock under the Base Case scenario is 28.93 NOK. Compared to the current market price of 21.1 NOK, Carasent ASA is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CARA Relative Value
Base Case
28.93 NOK
Undervaluation 27%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
74
vs Industry
27
Median 3Y
6
Median 5Y
9.2
Industry
2.3
Forward
5.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
22
Median 3Y
-17.2
Median 5Y
-23.9
Industry
23.1
Forward
188.1
More Details
79.8
P/OCF
P/OCF
Price to OCF
79.8
vs History
25
vs Industry
20
Median 3Y
46
Median 5Y
48.1
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-28.2
Median 5Y
-30.3
Industry
20.1
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
52
vs Industry
57
Median 3Y
1.3
Median 5Y
1.6
Industry
2.2
More Details
4.7
EV/S
EV/S
Enterprise Value to Sales
4.7
vs History
58
vs Industry
34
Median 3Y
3.8
Median 5Y
6.5
Industry
2.4
Forward
4.2
More Details
5.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.6
vs History
58
vs Industry
51
Median 3Y
4.6
Median 5Y
7.8
Industry
5
More Details
49.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
49.2
vs History
47
vs Industry
5
Median 3Y
35.5
Median 5Y
45
Industry
12.7
Forward
28
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
116
Industry
17.1
Forward
-64.5
More Details
61.9
EV/OCF
EV/OCF
Enterprise Value to OCF
61.9
vs History
26
vs Industry
45
Median 3Y
23.3
Median 5Y
42.7
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-7.8
Industry
18
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
57
vs Industry
54
Median 3Y
1.4
Median 5Y
1.9
Industry
1.9
More Details

Multiples Across Competitors

CARA Competitors Multiples
Carasent ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Carasent ASA
OSE:CARA
1.5B NOK 6 -146.9 49.2 -36.5
US
Veeva Systems Inc
NYSE:VEEV
36.1B USD 13.7 54.5 45.9 48.6
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.7B AUD 160.4 322.2 225.5 225.5
US
Doximity Inc
NYSE:DOCS
10.7B USD 20.9 62.2 46.8 49.2
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 7 -120.2 24.7 68.8
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.5B USD 7.3 166 277.3 377.8
SE
Sectra AB
STO:SECT B
53.5B SEK 29.5 119.5 -71.4 -71.4
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -294.8 239.5 3 835.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.2B CNY 5.1 45.1 32.4 32.4
P/E Multiple
Earnings Growth P/E to Growth
NO
C
Carasent ASA
OSE:CARA
Average P/E: 105.8
Negative Multiple: -146.9 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
54.5
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
322.2
131%
2.5
US
Doximity Inc
NYSE:DOCS
62.2
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.2 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
166
N/A N/A
SE
Sectra AB
STO:SECT B
119.5
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -294.8 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
45.1
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
C
Carasent ASA
OSE:CARA
Average EV/EBITDA: 97.5
49.2
775%
0.1
US
Veeva Systems Inc
NYSE:VEEV
45.9
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.5
130%
1.7
US
Doximity Inc
NYSE:DOCS
46.8
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
277.3
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
239.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
C
Carasent ASA
OSE:CARA
Average EV/EBIT: 521.6
Negative Multiple: -36.5 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
48.6
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.5
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.2
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
68.8
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
377.8
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 835.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
123%
0.3

See Also

Summary
CARA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CARA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CARA stock valuation using valuation multiples.
Wall Street Estimates
CARA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CARA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.